Annual D&A
$5.19M$3.15M+154.31%
Summary
- Current Value
- As of today, ACLX annual D&A is $5.19M, up +154.31% on
- Historical Performance
- ACLX annual D&A is up +398.37% over the past 3 years, and up +1491.41% over the past 5 years
- All-Time High Comparison
- ACLX annual D&A is currently at its all-time high
- 3-Year Low Comparison
- ACLX annual D&A is +292.73% above its 3-year low of $1.32M reached on an earlier date
- Sector Comparison
- ACLX annual D&A is higher than 63.00% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $5.19M | +154.3% | +398.4% | +1491.4% | +1491.4% | |
| Quarterly D&A | $1.84M | +38.2% | +179.2% | – | – | |
| TTM D&A | $6.83M | +65.6% | +356.0% | – | – | |
| Price | $68.05 | +3.3% | +111.2% | – | – | |
| Annual SG&A | $88.41M | +33.3% | +387.5% | +3904.3% | +3904.3% | |
| Annual Total Expenses | $245.51M | +22.6% | +277.6% | +1265.9% | +1265.9% | |
| Annual Operating Expenses | $245.51M | +22.6% | +277.6% | +1265.9% | +1265.9% | |
| Annual Revenue | $107.94M | -2.2% | +100.0% | +100.0% | +100.0% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.19M | at high | |
| 5Y | $5.19M | at high | |
| All | $5.19M | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.32M | N/A | +292.7% |
| 5Y | $629.00K | N/A | +724.8% |
| All | $326.00K | +1491.4% |
Depreciation & Amortization History
| Year | Value | Change |
|---|---|---|
| $5.19M | +154.3% | |
| $2.04M | +54.4% | |
| $1.32M | +26.9% |
| Year | Value | Change |
|---|---|---|
| $1.04M | +65.5% | |
| $629.00K | +92.9% | |
| $326.00K | - |
FAQ
What is the current annual D&A of ACLX?
As of today, ACLX annual D&A is $5.19M
What is 1-year change in ACLX annual D&A?
ACLX annual D&A is up +154.31% year-over-year
What is 3-year change in ACLX annual D&A?
ACLX annual D&A is up +398.37% over the past 3 years
How far is ACLX annual D&A from its all-time high?
ACLX annual D&A is currently at its all-time high
How does ACLX annual D&A rank versus sector peers?
ACLX annual D&A is higher than 63.00% of companies in Healthcare sector
When is ACLX next annual earnings release?
The next annual earnings release for ACLX is on
Quarterly D&A
$1.84M$225.00K+13.91%
Summary
- Current Value
- As of today, ACLX quarterly D&A is $1.84M, up +13.91% on
- Historical Performance
- ACLX quarterly D&A is up +38.16% year-over-year, and up +179.24% over the past 3 years
- All-Time High Comparison
- ACLX quarterly D&A is currently at its all-time high
- 3-Year Low Comparison
- ACLX quarterly D&A is +1610.66% above its 3-year low of -$122.00K reached on
- Sector Comparison
- ACLX quarterly D&A is higher than 65.56% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $1.84M | +13.9% | +38.2% | +179.2% | – | |
| Annual D&A | $5.19M | – | +154.3% | +398.4% | +1491.4% | |
| TTM D&A | $6.83M | +8.1% | +65.6% | +356.0% | – | |
| Price | $68.05 | -18.4% | +3.3% | +111.2% | – | |
| Quarterly SG&A | $31.64M | +10.4% | +54.5% | +204.1% | +1356.6% | |
| Quarterly Total Expenses | $60.73M | +0.7% | +17.0% | -34.6% | +567.9% | |
| Quarterly Operating Expenses | $64.88M | +0.3% | +11.3% | -30.4% | +626.6% | |
| Quarterly Revenue | $4.95M | -34.5% | -81.0% | +100.0% | +100.0% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.84M | at high | |
| 3Y | $1.84M | at high | |
| 5Y | $1.84M | at high | |
| All | $1.84M | at high |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.58M | +16.9% | |
| 3Y | -$122.00K | +1610.7% | |
| 5Y | -$122.00K | +1610.7% | |
| All | -$122.00K | +1610.7% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of ACLX?
As of today, ACLX quarterly D&A is $1.84M
What is ACLX quarterly D&A most recent change?
ACLX quarterly D&A was up +13.91% on September 30, 2025
What is 1-year change in ACLX quarterly D&A?
ACLX quarterly D&A is up +38.16% year-over-year
How far is ACLX quarterly D&A from its all-time high?
ACLX quarterly D&A is currently at its all-time high
How does ACLX quarterly D&A rank versus sector peers?
ACLX quarterly D&A is higher than 65.56% of companies in Healthcare sector
When is ACLX next earnings release?
The next earnings release for ACLX is on
TTM D&A
$6.83M$509.00K+8.06%
Summary
- Current Value
- As of today, ACLX TTM D&A is $6.83M, up +8.06% on
- Historical Performance
- ACLX TTM D&A is up +65.64% year-over-year, and up +355.98% over the past 3 years
- All-Time High Comparison
- ACLX TTM D&A is currently at its all-time high
- 3-Year Low Comparison
- ACLX TTM D&A is +234.61% above its 3-year low of $2.04M reached on
- Sector Comparison
- ACLX TTM D&A is higher than 64.88% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $6.83M | +8.1% | +65.6% | +356.0% | – | |
| Annual D&A | $5.19M | – | +154.3% | +398.4% | +1491.4% | |
| Quarterly D&A | $1.84M | +13.9% | +38.2% | +179.2% | – | |
| Price | $68.05 | -18.4% | +3.3% | +111.2% | – | |
| TTM SG&A | -$2.34B | -2456.2% | -2880.0% | -6782.8% | -10000.0% | |
| TTM Revenue | $35.90M | -37.0% | -77.0% | +100.0% | +100.0% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $6.83M | at high | |
| 3Y | $6.83M | at high | |
| 5Y | $6.83M | at high | |
| All | $6.83M | at high |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $5.19M | N/A | +31.6% |
| 3Y | $2.04M | +234.6% | |
| 5Y | $207.00K | +3197.6% | |
| All | $207.00K | +3197.6% |
TTM D&A History
FAQ
What is the current TTM D&A of ACLX?
As of today, ACLX TTM D&A is $6.83M
What is ACLX TTM D&A most recent change?
ACLX TTM D&A was up +8.06% on September 30, 2025
What is 1-year change in ACLX TTM D&A?
ACLX TTM D&A is up +65.64% year-over-year
How far is ACLX TTM D&A from its all-time high?
ACLX TTM D&A is currently at its all-time high
How does ACLX TTM D&A rank versus sector peers?
ACLX TTM D&A is higher than 64.88% of companies in Healthcare sector
When is ACLX next earnings release?
The next earnings release for ACLX is on
Data Sources & References
- ACLX Official Website www.arcellx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1786205/000119312525266932/0001193125-25-266932-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1786205/000095017025029150/0000950170-25-029150-index.htm
- ACLX Profile on Yahoo Finance finance.yahoo.com/quote/ACLX
- ACLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aclx